We use cookies to improve the function of this site and enhance the user experience.
Learn more about our cookie policy and how to modify your cookie settings.
UK/CORP/15-0012l. Date of preparation: July 2015
United Kingdom
Include All CSL Behring Country Sites
For Healthcare Professionals
CSL Behring is committed to improving the quality of life for patients with rare and serious diseases. The company develops, manufactures and markets a range of products including:
Coagulation therapies
For rapid warfarin reversal, von Willebrand disease, haemophilia and congenital fibrinogen deficiency
Immunology therapies
For hereditary angioedema, immune deficiency disorders, neurological disorders and haemolytic disease of the newborn

Healthcare professionals can access product SPCs via the links above

For Patients

Customer Services

Adverse events should be reported.

Reporting forms and information can be found at www.mhra.gov.uk/yellowcard

Adverse events should be reported to CSL Behring UK Ltd on 01444 447405